Wickramasinghe

TL2 Member · Regensburg, DE

Based in the EU. Tracks what is available and funded locally, and dates every claim.

Joined 5 October 2024 · last posted 3d · groups: regional-eu

72 posts, newest first. Showing up to 150.

Reflectance and photometric devices: precision in practice — a second dataset Replied, post #81 · Analytics › Home & field testing · 25 Jul 2026 · 2 likes Practical experience of Reflectance and photometric devices, offered as one case with the conditions stated, not as a general finding. Conditions first, because they…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #67 · Practice › Side effects · 22 Jul 2026 · 6 likes Adding the measurement that post #65 says would settle it. I changed my mind about Muscle cramps after someone here asked me for the source and I could not produce one.…
Tracking a shortage from primary sources rather than rumour Replied, post #113 · Access › Shortages · 20 Jul 2026 · 20 likes Noted, and thank you for writing it out rather than summarising it.
Common supplements people ask about, assessed one at a time Replied, post #69 · Practice › Interactions · 19 Jul 2026 · 13 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #27 · Access › Insurance & coverage · 14 Jul 2026 · 0 likes Following this. I have the same question and no better information than the first post.
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #62 · Access › International · 7 Jul 2026 · 21 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Coming back to: A structured critique template this community uses Replied, post #51 · Evidence › Study critique · 6 Jul 2026 · 28 likes Post #49 and I disagree about the size of the effect, not about the direction. Structured critique template is a question about a distribution, not about a value, and…
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #16 · Analytics › Home & field testing · 5 Jul 2026 · 9 likes Cost versus information sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Coming back to: Time to steady state after a dose increase Replied, post #92 · Pharmacology › Pharmacokinetics · 4 Jul 2026 · 0 likes The time to maximum concentration after a subcutaneous dose in this class is measured in days rather than hours, which surprises people expecting an injection to act…
Restarting after a long gap: what the labelling implies Replied, post #9 · Practice › Dosing & titration · 2 Jul 2026 · 6 likes Narrowing post #8, because the general version has more than one answer. Steady state means the plasma concentration is stable from dose to dose. That happens around 4…
Follow-up: Reading an interaction checker output critically Replied, post #19 · Practice › Interactions · 26 Jun 2026 · 0 likes Confirming post #16 from a second method, which matters more than confirming it from a second person. Where a published interaction study exists it usually reports an…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #81 · Devices › Syringes & needles · 22 Jun 2026 · 0 likes Practical note on 0.3 ml versus 0.5 ml: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #23 · Sourcing › Red flags · 3 Jun 2026 · 5 likes Post #21 describes the usual case. This is about the unusual one. The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into…
Comparing prices across jurisdictions without misleading yourself Replied, post #22 · Access › Pricing · 31 May 2026 · 22 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion.
Prescription requirements and telehealth models — a second dataset Replied, post #30 · Sourcing › Regulatory · 15 May 2026 · 3 likes On post #26 — agreed on the reasoning, with one qualification. If you can confirm or contradict a position for your own region, please date the answer. An undated…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #63 · Evidence › Journal club · 14 May 2026 · 11 likes Orforglipron phase 2: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #26 · Compounds › Semaglutide · 14 May 2026 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Journal club: LEADER as the historical anchor Replied, post #73 · Evidence › Journal club · 12 May 2026 · 4 likes Checked the LEADER claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
Reading a trial's population section before its results Started this topic · Evidence › Trials · 4 May 2026 · 50 likes On the subject in the title: Reading a trial's population section before its results Working notes rather than a conclusion. Reading STEP 2 ( Lancet , 2021) for the…
Citation sweep results: how many references did not say what was claimed Replied, post #84 · Meta › Wiki maintenance · 26 Apr 2026 · 0 likes The question underneath citation sweep results is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
Spike-and-recover accuracy for a peptide assay Replied, post #57 · Analytics › Method validation · 9 Apr 2026 · 3 likes Posting my spike-and-recover accuracy numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted…
The best-written scientific paper you have read Started this topic · Lounge › Off topic · 8 Apr 2026 · 14 likes The best-written scientific paper you have read Writing it up because I had to work it out twice and would rather nobody else did. Asking about best-written scientific…
Bug report: the reconstitution calculator and a rounding edge case Replied, post #52 · Data & Tools › Calculators · 8 Apr 2026 · 0 likes Where I part company with post #50, and it is a narrow parting. Maintaining a calculator means checking the arithmetic against hand-worked cases at each review, not…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #36 · Data & Tools › Datasets · 11 Mar 2026 · 24 likes Post #35 answers the question as asked. The question underneath it is different. A codebook describing each field takes twenty minutes and is what makes the file usable…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #60 · Practice › Storage & stability · 10 Mar 2026 · 26 likes Following this. I have the same question and no better information than the first post.
The lowest dose that does anything: is that a real question? Replied, post #99 · Practice › Dosing & titration · 7 Mar 2026 · 0 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 4 Mar 2026 · 13 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #74 · Evidence › Study critique · 21 Feb 2026 · 10 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
Mass error in ppm: the arithmetic and the caveat Replied, post #124 · Analytics › Mass spectrometry · 16 Feb 2026 · 12 likes Post #120 put the caveat in the right place and I want to underline it. Combining a chromatographic result with a mass result is genuinely orthogonal confirmation.…
[2026 update] What a purity-only report leaves out Replied, post #15 · Sourcing › Independent verification · 3 Feb 2026 · 0 likes Answering the purity-only question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #41 · Practice › Side effects · 1 Feb 2026 · 27 likes Post #37 and I disagree about the size of the effect, not about the direction. The relationship between symptom burden and outcome is not what people assume. Feeling…
Storing lyophilised material long term: what governs the shelf life Replied, post #23 · Practice › Storage & stability · 12 Jan 2026 · 3 likes Thank you for taking the time. That was more work than a reply usually is.
What "verified" means on our vendor pages, stated narrowly Replied, post #12 · Sourcing › Vendor reports · 27 Dec 2025 · 1 like Building on post #9 rather than restating it. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Started this topic · Compounds › Repair & healing peptides · 13 Dec 2025 · 5 likes Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have…
A widely repeated interaction claim that turns out to be unsupported Replied, post #10 · Practice › Interactions · 8 Dec 2025 · 22 likes Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely high. Ask the prescriber or the pharmacist. The…
Liver enzymes drifting down and what that usually means Replied, post #28 · Clinical › Bloodwork · 17 Nov 2025 · 0 likes Careful with the language on liver enzymes drifting. "Not detected" and "not present" are different findings and the first is a statement about the method.
Comparing my trajectory with the trial curves, carefully Replied, post #73 · Outcomes › Progress reports · 8 Nov 2025 · 4 likes Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change once loss stops.
Coming back to: Why quantitation is the hard part, not detection Replied, post #84 · Analytics › Home & field testing · 25 Oct 2025 · 29 likes The strongest argument against my own position on quantitation, stated as well as I can state it, since nobody else has yet.
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #65 · Start Here › Welcome · 18 Oct 2025 · 0 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #66 · Lounge › Off topic · 30 Sep 2025 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Pinch or no pinch, and how needle length changes the answer Replied, post #74 · Practice › Administration · 22 Sep 2025 · 8 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #24 · Evidence › Study critique · 13 Sep 2025 · 10 likes That is the distinction I keep failing to hold on to. Written down now.
Power cut for eleven hours: how I assessed it afterwards Replied, post #49 · Practice › Storage & stability · 7 Sep 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. On balance I…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #14 · Compounds › Tirzepatide · 7 Sep 2025 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #109 · Practice › Reconstitution · 20 Aug 2025 · 8 likes Small methodological point on 10 mg vial reconstituted three: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
What a documentation review can and cannot tell you Replied, post #78 · Sourcing › Independent verification · 18 Aug 2025 · 1 like That reframing is the whole thing. The facts I already had.
A ten-fold dose error caught before injection — one year on Replied, post #63 · Devices › Syringes & needles · 3 Aug 2025 · 27 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #29 · Compounds › Retatrutide · 30 Jul 2025 · 27 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
A field-by-field walk through a certificate of analysis Replied, post #9 · Analytics › COA interpretation · 14 Jul 2025 · 28 likes Adding a data point of agreement rather than a data point.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #42 · Access › Insurance & coverage · 12 Jul 2025 · 6 likes Coming back to post #38, because the follow-up matters more than the original answer. Formulary changes happen on a published schedule, so a denial now may be answering…
[2026 update] An appeal that failed, and what I would do differently Replied, post #107 · Access › Insurance & coverage · 14 Jun 2025 · 9 likes Adding a data point of agreement rather than a data point.
Coming back to: Getting a referral rather than a refusal Replied, post #66 · Clinical › Prescriber conversations · 13 Jun 2025 · 8 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #71 · Compounds › Cagrilintide & amylin analogues · 12 Jun 2025 · 0 likes I read the earlier replies on CagriSema phase 2 paper twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #52 · Nutrition & Training › Protein & intake · 9 Jun 2025 · 25 likes Post #48 and I disagree about the size of the effect, not about the direction. Self-reported intake is optimistic by a consistent margin in the published comparisons,…
[2026 update] US compounding rules and how they changed Replied, post #13 · Regional › North America · 14 May 2025 · 5 likes Bookmarking this. I will come back when I have something worth adding.
Coming back to: Sample size calculations, read backwards from the published number Replied, post #21 · Evidence › Trials · 5 May 2025 · 0 likes Taking post #20 at face value and following it one step further. Absolute and relative effects answer different questions. Write down the event rate in each arm and the…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #34 · Compounds › Retatrutide · 2 May 2025 · 18 likes On post #32 — agreed on the reasoning, with one qualification. On identity confirmation more generally: for a compound with no widely available reference material,…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #4 · Evidence › Journal club · 17 Mar 2025 · 15 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #23 · Compounds › Retatrutide · 9 Mar 2025 · 15 likes This follows post #22 rather than contradicting it. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #24 · Clinical › Comorbidities · 1 Mar 2025 · 1 like Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
When "no data" is the complete and final answer Replied, post #98 · Compounds › Other compounds · 20 Feb 2025 · 9 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #27 · Sourcing › Vendor reports · 28 Jan 2025 · 18 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
Escalating every six weeks instead of four: what I observed over eight months Replied, post #29 · Practice › Dosing & titration · 21 Jan 2025 · 7 likes On escalating every six weeks instead the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #47 · Nutrition & Training › Protein & intake · 9 Dec 2024 · 8 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #7 · Sourcing › Vendor reports · 20 Nov 2024 · 0 likes An observation about Reporting a good result that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than…
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #20 · Sourcing › Independent verification · 5 Nov 2024 · 4 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Irish differences from the UK position Replied, post #60 · Regional › UK & Ireland · 26 Oct 2024 · 0 likes I read the earlier replies on irish differences twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
SURPASS-2 and the comparator dose question that will not go away Replied, post #31 · Compounds › Tirzepatide · 10 Oct 2024 · 0 likes This follows post #30 rather than contradicting it. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent…
Circumference measurements as a poor man's composition estimate Replied, post #79 · Outcomes › Body composition · 19 Aug 2024 · 0 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
Reading a meta-analysis you disagree with, fairly Replied, post #11 · Evidence › Meta-analyses · 16 Aug 2024 · 0 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #23 · Safety › Contraindications · 22 Jul 2024 · 6 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Oral contraceptives and delayed emptying: what the data shows Replied, post #12 · Practice › Interactions · 7 Jul 2024 · 3 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…